The World Health Organisation CBD report
The World Health Organisation CBD report, was published on in 2018 that got everyone talking, but what exactly did it say?
The WHO CBD report is a complex read, and as a result, many people don’t fancy tackling the full thing themselves, which is totally fair enough.
There are many people who claim to bring the full facts of the WHO study, but unfortunately, this can often not be the case. Claims that the WHO report condemns CBD, and contrasting claims that it states proof of CBD being a cure for multiple medical conditions can be found in multiple places.
However, neither of these claims are quite correct, the truth lies in the middle, as it so often does.
So let’s take a second to break down the important factors of the WHO report, and what it means for CBD products.
CBD is Generally Safe
Arguably the most important aspect of the WHO CBD report is the answer to the often asked question, is CBD safe?
The report answers this question about as firmly as it can in the current climate, saying “CBD is generally well tolerated with a good safety profile”.
The report goes on to explain that in cases where there were negative effects, these were likely to be due to mixing CBD with other medications:
“Reported adverse effects may be as a result of drug-drug interactions between CBD and patients’ existing medications”
The report also gives a response to concerns that CBD could cause a public safety issue, and again, the answer is firm:
“To date, there is no evidence of recreational use of CBD or any public health-related problems associated with the use of pure CBD”.
The report later adds to this, saying:
“While the number of studies is limited, the evidence from well-controlled human experimental research indicates that CBD is not associated with abuse potential”.
The World Health Organisation CBD report on Epilepsy
The one medical condition that the report openly states that CBD is beneficial for is epilepsy:
“CBD has been demonstrated as an effective treatment of epilepsy in several clinical trials”.
The report goes onto speak of Epidiolex, a pure CBD product which was, at the time, waiting for approval after completing Phase III trials.
Since the report, Epidiolex has become the first (and so far, only) drug to gain FDA approval, and is now available on prescription in the USA.
Other Potential CBD Medical Benefits
While the lack of completed scientific research means the WHO is currently unable to state that CBD is good for other medical conditions, there is a tone of optimism to the report.
“There is also evidence that CBD may be a useful treatment for a number of other medical conditions”.
Although a caveat is attached here:
“However, this research is considerably less advanced than for the treatment of epilepsy.
“For most indications, there is only pre-clinical evidence, while for some there is a combination of the pre-clinical and limited clinical evidence”.
That doesn’t mean the report doesn’t mention possible benefits though, saying:
“The range of conditions for which CBD has been assessed is diverse, consistent with its neuroprotective, antiepileptic, hypoxia-ischemia, anxiolytic, antipsychotic, analgesic, anti-inflammatory, anti-asthmatic, and antitumor properties”.
The report then goes on to discuss the possibility of CBD also helping with reducing the risk of disease after transplants, aiding patients with schizophrenia, reduce symptoms of chronic pain in kidney transplant patients, treating drug addiction, and more.
The World Health Organisation CBD report on the Future CBD Drugs
Epidiolex isn’t the only drug mentioned in the WHO CBD report, with Arvisol, Bionorica, Zynerba, and more mentioned as possible drugs to be added to the market in the future.
With the FDA recently seeming to have taken a negative turn towards CBD (more on this in another article) it is unknown whether these drugs will follow in the footsteps of Epidiolex and gain approval.
However, there is certainly a sense of optimism to the WHO CBD report from 2018, and all eyes are on the next big statement to be made by the World Health Organisation.